跳至主要内容
临床试验/NCT06604169
NCT06604169进行中(未招募)不适用

An Observational Study of Subcutaneous Implantable Cardioverter Defibrillator in Patients with Hypertrophic Cardiomyopathy At High Risk of Sudden Cardiac Death

China National Center for Cardiovascular Diseases1 个研究点 分布在 1 个国家目标入组 589 人开始时间: 2024年8月1日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
589
试验地点
1
主要终点
the failure rate of S-ICD screening

研究概览

简要总结

  1. To observe the failure rate of S-ICD screening in HCM patients at high risk of SCD.
  2. To observe the incidence of IAS in HCM patients with S-ICD implantation and explore the related factors of IAS.

详细描述

The study was a multicenter, prospective, observational study that prospectively included HCM patients assessed as meeting the ICD implantation indication at Fuwai Hospital and National Collaborative Hospitals from July 1, 2024 to June 30, 2027, for pre-operation screening of S-ICD, and follow-up of patients eventually implanted with S-ICD.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
14 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • HCM patients assessed as meeting the ICD implantation indication

排除标准

  • Combined with bradycardia with pacing indications;
  • Frequent monomorphic ventricular tachycardia require ATP therapy;
  • With indications of CRT;
  • Combined with other diseases, life expectancy is less than 1 year.

结局指标

主要结局

the failure rate of S-ICD screening

时间窗: 3 months

S-ICD screening failed

The inappropriate shock event

时间窗: 3 months

The incidence of inappropriate shock event

次要结局

未报告次要终点

研究者

发起方
China National Center for Cardiovascular Diseases
申办方类型
Other Gov
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验